R&D
Research & Development
Development of preclinical and translational models for Future Therapies
Our Research & Development efforts are expanding toward the developing new preclinical solutions, with a focus on rare diseases and innovative therapeutic approaches. We aim to develop cutting-edge methodologies to evaluate the efficacy, safety, and mechanism of action of novel compounds.
Advanced preclinical models
to assess drug response and disease progression
Molecular and cellular characterization
of new drug candidates
Biomarker-driven approaches
for therapy optimization
Project Ongoing
Development of new diagnostic markers
Preclinic Services identifies and validates novel diagnostic markers, enhancing early disease detection, patient monitoring, and treatment precision.
Smell loss in aging
Preclinic Services studies age-related smell loss, exploring its causes, impact on health, and potential therapeutic solutions to improve quality of life.
Retinal disorder in aging
Preclinic Services investigates age-related retinal disorders, focusing on their mechanisms, progression, and potential treatments to preserve vision and improve patient outcomes.
Osteoartritis induced by surgery
Preclinic Services develops preclinical models of surgery-induced osteoarthritis to study disease progression and evaluate potential treatments for joint degeneration.